Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis

  Free Subscription

Articles published in
Gastroenterol Hepatol
    June 2025
  1. FERNANDEZ AS, Valbuena MB, Arroba CM, Dominguez EG, et al
    Prognostic value of early Lille score in patients with severe alcohol-associated hepatitis.
    Gastroenterol Hepatol. 2025 Jun 20:502517. doi: 10.1016/j.gastrohep.2025.502517.
    >> Share

  2. CRESPO J, Albillos A, Buti M
    The Spanish National Strategic Plan for Hepatitis C: A legacy of success.
    Gastroenterol Hepatol. 2025 Jun 13:502457. doi: 10.1016/j.gastrohep.2025.502457.
    >> Share

    February 2025
  3. ROMERO-VICO J, Vargas-Accarino E, Palom A, Fabrellas N, et al
    Utility of mobile applications in the management of hepatitis B: A systematic review.
    Gastroenterol Hepatol. 2025 Feb 19:502395. doi: 10.1016/j.gastrohep.2025.502395.
    >> Share

    January 2025
  4. LUIS CASTRO URDA J, Alvarez M, Cantero H, Ayala V, et al
    The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with undiagnosed HCV infection (Intelligen-C strategy).
    Gastroenterol Hepatol. 2025 Jan 18:502362. doi: 10.1016/j.gastrohep.2025.502362.
    >> Share

  5. FORNS X, Rodriguez M, Dominguez-Hernandez R, Cantero H, et al
    Cost analysis of hidden hepatitis D virus infection in Spain.
    Gastroenterol Hepatol. 2025 Jan 8:502337. doi: 10.1016/j.gastrohep.2025.502337.
    >> Share

    December 2024
  6. JIMENEZ-CASTILLO RA, Gonzalez-Martinez CE, Tovar-Bojorquez EM, Cortez-Hernandez CA, et al
    Prognostic value of relative adrenal insufficiency in patients with severe alcohol-associated hepatitis-a prospective clinical study.
    Gastroenterol Hepatol. 2024 Dec 12:502322. doi: 10.1016/j.gastrohep.2024.502322.
    >> Share

    November 2024
  7. LOPEZ DE LA CRUZ J, Gonzalvo MCA, Ortiz de Solorzano Reig M, Aguilar A, et al
    Acute cholestatic hepatitis secondary to idiopathic adult ductopenia.
    Gastroenterol Hepatol. 2024 Nov 14:502289. doi: 10.1016/j.gastrohep.2024.502289.
    >> Share

  8. MIRALPEIX A, Ibanez P, Navarro V, Colomera P, et al
    Externalised nurse-led model for hepatitis C virus microelimination and impact of drug use profile.
    Gastroenterol Hepatol. 2024 Nov 13:502288. doi: 10.1016/j.gastrohep.2024.502288.
    >> Share

    October 2024
  9. LUO JX, Chen G, Hu XY, Yu C, et al
    Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis.
    Gastroenterol Hepatol. 2024 Oct 17:502276. doi: 10.1016/j.gastrohep.2024.502276.
    >> Share

    September 2024
  10. BUTI M, Calleja JL, Rodriguez MA, Dominguez-Hernandez R, et al
    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.
    Gastroenterol Hepatol. 2024 Sep 7:502241. doi: 10.1016/j.gastrohep.2024.502241.
    >> Share

    June 2024
  11. BOLIS F, Cazzaniga G, Pagni F, Invernizzi P, et al
    The phenotypic landscape of primary biliary cholangitis and autoimmune hepatitis variants.
    Gastroenterol Hepatol. 2024 Jun 29:502225. doi: 10.1016/j.gastrohep.2024.502225.
    >> Share

  12. PARADA VAZQUEZ P, Perez-Cachafeiro S, Castineira Dominguez B, Gonzalez-Perez JM, et al
    Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnes (Spain).
    Gastroenterol Hepatol. 2024 Jun 29:502226. doi: 10.1016/j.gastrohep.2024.502226.
    >> Share

  13. RODRIGUEZ-TAJES S, Palom A, Giraldez Gallego A, Moreno A, et al
    Characterizing Hepatitis Delta in Spain and the gaps in its management.
    Gastroenterol Hepatol. 2024 Jun 20:502222. doi: 10.1016/j.gastrohep.2024.502222.
    >> Share

    May 2024
  14. ESTEBAN R, Hernandez RD, Cantero H, Casado MA, et al
    Evaluacion del valor clinico y economico de sofosbuvir/velpatasvir (SOF/VEL) en pacientes con hepatitis C cronica en Espana durante los ultimos 5 anos.
    Gastroenterol Hepatol. 2024 May 7:502199. doi: 10.1016/j.gastrohep.2024.502199.
    >> Share

    February 2024
  15. JORQUERA F, Ledesma F, Ahumada A, Manzano ML, et al
    Clinical profile of Spanish hepatitis C virus-infected treatment-naive patients with compensated cirrhosis in the CREST study.
    Gastroenterol Hepatol. 2024 Feb 12:S0210-5705(24)00037.
    >> Share

  16. LIU Y, Chen S, Yu S, Wang J, et al
    LPS-TLR4 pathway exaggerates alcoholic hepatitis via provoking NETs formation.
    Gastroenterol Hepatol. 2024;47:158-169.
    >> Share

    December 2023
  17. CONTHE A, Ahumada A, Gallego Duran R, Marti-Aguado D, et al
    Current dilemmas in hepatitis virus C management. What should we do after achieving sustained virologic response?
    Gastroenterol Hepatol. 2023;46:826-829.
    >> Share

  18. RIVEIRO-BARCIELA M, Roade L, Martinez-Camprecios J, Vidal-Gonzalez J, et al
    mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
    Gastroenterol Hepatol. 2023;46:764-773.
    >> Share

  19. ARZALLUS T, Izagirre A, Castiella A, Torrente S, et al
    Drug induced autoimmune hepatitis after turmeric intake.
    Gastroenterol Hepatol. 2023;46:805-806.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016